Volume 10 Issue 5
Sep.  2019
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2019  >  10(5): 612-616
Zhang Liyi, Tong Calling, An Ke, et al. Research progress on immunosuppressive effect and mechanism of mesenchymal stem cells in organ transplantation[J]. ORGAN TRANSPLANTATION, 2019, 10(5): 612-616. doi: 10.3969/j.issn.1674-7445.2019.05.025
Citation: Zhang Liyi, Tong Calling, An Ke, et al. Research progress on immunosuppressive effect and mechanism of mesenchymal stem cells in organ transplantation[J]. ORGAN TRANSPLANTATION, 2019, 10(5): 612-616. doi: 10.3969/j.issn.1674-7445.2019.05.025
shu

Research progress on immunosuppressive effect and mechanism of mesenchymal stem cells in organ transplantation

doi: 10.3969/j.issn.1674-7445.2019.05.025
  • Received Date: 2019-06-13
    Available Online: 2021-01-19
  • Publish Date: 2019-09-15
    Abstract
    • FullText(HTML)
  • loading
    • References(48)
  • [1]
    HOOGDUIJN MJ, LOMBARDO E. Concise review: mesenchymal stromal cells anno 2019: dawn of the therapeutic era?[J]. Stem Cells Transl Med, 2019, DOI:10.1002/sctm.19-0073[Epub ahead of print].
    [2]
    VAN MEGEN KM, VAN'T WOUT ET, LAGES MOTTA J, et al. Activated mesenchymal stromal cells process and present antigens regulating adaptive immunity[J]. Front Immunol, 2019, 10:694. DOI: 10.3389/fimmu.2019.00694.
    [3]
    LUK F, CARRERAS-PLANELLA L, KOREVAAR SS, et al. Inflammatory conditions dictate the effect of mesenchymal stem or stromal cells on B cell function[J]. Front Immunol, 2017, 8:1042. DOI: 10.3389/fimmu.2017.01042.
    [4]
    CHO DI, KIM MR, JEONG HY, et al. Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages[J]. Exp Mol Med, 2014, 46:e70. DOI: 10.1038/emm.2013.135.
    [5]
    VASANDAN AB, JAHNAVI S, SHASHANK C, et al. Human mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE2-dependent mechanism[J]. Sci Rep, 2016, 6:38308. DOI: 10.1038/srep38308.
    [6]
    PRIGIONE I, BENVENUTO F, BOCCA P, et al. Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells[J]. Stem Cells, 2009, 27(3):693-702. DOI: 10.1634/stemcells.2008-0687.
    [7]
    DAVIES LC, HELDRING N, KADRI N, et al. Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression[J]. Stem Cells, 2017, 35(3):766-776. DOI: 10.1002/stem.2509.
    [8]
    GALLEU A, RIFFO-VASQUEZ Y, TRENTO C, et al. Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation[J]. Sci Transl Med, 2017, 9(416). DOI: 10.1126/scitranslmed.aam7828.
    [9]
    GALIPEAU J, SENSÉBÉ L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities[J]. Cell Stem Cell, 2018, 22(6):824-833. DOI: 10.1016/j.stem.2018.05.004.
    [10]
    CASTRO-MANRREZA ME, MONTESINOS JJ. Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications[J]. J Immunol Res, 2015:394917. DOI: 10.1155/2015/394917.
    [11]
    KOCAN B, MAZIARZ A, TABARKIEWICZ J, et al. Trophic activity and phenotype of adipose tissue-derived mesenchymal stem cells as a background of their regenerative potential[J]. Stem Cells Int, 2017:1653254. DOI: 10.1155/2017/1653254.
    [12]
    ALANAZI A, MUNIR H, ALASSIRI M, et al. Comparative adhesive and migratory properties of mesenchymal stem cells from different tissues[J]. Biorheology, 2019, 56(1):15-30. DOI: 10.3233/BIR-180185.
    [13]
    JARVINEN L, BADRI L, WETTLAUFER S, et al. Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator[J]. J Immunol, 2008, 181(6):4389-4396. doi: 10.4049/jimmunol.181.6.4389
    [14]
    PLOCK JA, SCHNIDER JT, ZHANG W, et al. Adipose- and bone marrow-derived mesenchymal stem cells prolong graft survival in vascularized composite allotransplantation[J]. Transplantation, 2015, 99(9):1765-1773. DOI: 10.1097/TP.0000000000000731.
    [15]
    EGGENHOFER E, RENNER P, SOEDER Y, et al. Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model[J]. Transpl Immunol, 2011, 25(2/3):141-147. DOI: 10.1016/j.trim.2011.06.002.
    [16]
    ESTRADA JC, ALBO C, BENGURÍA A, et al. Culture of human mesenchymal stem cells at low oxygen tension improves growth and genetic stability by activating glycolysis[J]. Cell Death Differ, 2012, 19(5):743-755. DOI: 10.1038/cdd.2011.172.
    [17]
    KADLE RL, ABDOU SA, VILLARREAL-PONCE AP, et al. Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion[J]. PLoS One, 2018, 13(3):e0193178. DOI: 10.1371/journal.pone.0193178.
    [18]
    FOTIA C, MASSA A, BORIANI F, et al. Hypoxia enhances proliferation and stemness of human adipose-derived mesenchymal stem cells[J]. Cytotechnology, 2015, 67(6):1073-1084. DOI: 10.1007/s10616-014-9731-2.
    [19]
    ZHU C, YU J, PAN Q, et al. Hypoxia-inducible factor-2 alpha promotes the proliferation of human placenta-derived mesenchymal stem cells through the MAPK/ERK signaling pathway[J]. Sci Rep, 2016, 6:35489. DOI: 10.1038/srep35489.
    [20]
    LV B, LI F, FANG J, et al. Hypoxia inducible factor 1α promotes survival of mesenchymal stem cells under hypoxia[J]. Am J Transl Res, 2017, 9(3):1521-1529. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xdkf201623006
    [21]
    LIU C, TSAI AL, LI PC, et al. Endothelial differentiation of bone marrow mesenchyme stem cells applicable to hypoxia and increased migration through Akt and NFκB signals[J]. Stem Cell Res Ther, 2017, 8(1):29. DOI: 10.1186/s13287-017-0470-0.
    [22]
    LAN YW, CHOO KB, CHEN CM, et al. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis[J]. Stem Cell Res Ther, 2015, 6:97. DOI: 10.1186/s13287-015-0081-6.
    [23]
    JIANG CM, LIU J, ZHAO JY, et al. Effects of hypoxia on the immunomodulatory properties of human gingiva-derived mesenchymal stem cells[J]. J Dent Res, 2015, 94(1):69-77. DOI: 10.1177/0022034514557671.
    [24]
    WOBMA HM, KANAI M, MA SP, et al. Dual IFN-γ/hypoxia priming enhances immunosuppression of mesenchymal stromal cells through regulatory proteins and metabolic mechanisms[J]. J Immunol Regen Med, 2018, 1:45-56. DOI: 10.1016/j.regen.2018.01.001.
    [25]
    SALA E, GENUA M, PETTI L, et al. Mesenchymal stem cells reduce colitis in mice via release of TSG6, independently of their localization to the intestine[J]. Gastroenterology, 2015, 149(1):163-176. DOI: 10.1053/j.gastro.2015.03.013.
    [26]
    HAJKOVA M, HERMANKOVA B, JAVORKOVA E, et al. Mesenchymal stem cells attenuate the adverse effects of immunosuppressive drugs on distinct T cell subopulations[J]. Stem Cell Rev, 2017, 13(1):104-115. DOI: 10.1007/s12015-016-9703-3.
    [27]
    INOUE S, POPP FC, KOEHL GE, et al. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model[J]. Transplantation, 2006, 81(11):1589-1595. doi: 10.1097/01.tp.0000209919.90630.7b
    [28]
    HAJKOVA M, JAVORKOVA E, ZAJICOVA A, et al. A local application of mesenchymal stem cells and cyclosporine A attenuates immune response by a switch in macrophage phenotype[J]. J Tissue Eng Regen Med, 2017, 11(5):1456-1465. DOI: 10.1002/term.2044.
    [29]
    GE W, JIANG J, BAROJA ML, et al. Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance[J]. Am J Transplant, 2009, 9(8):1760-1772. DOI: 10.1111/j.1600-6143.2009.02721.x.
    [30]
    SONG Y, WANG Z, WANG Z, et al. Use of FK506 and bone marrow mesenchymal stem cells for rat hind limb allografts[J]. Neural Regen Res, 2012, 7(34):2681-2688. DOI: 10.3969/j.issn.1673-5374.2012.34.005.
    [31]
    AN JH, SONG WJ, LI Q, et al. Prostaglandin E2 secreted from feline adipose tissue-derived mesenchymal stem cells alleviate DSS-induced colitis by increasing regulatory T cells in mice[J]. BMC Vet Res, 2018, 14(1):354. DOI: 10.1186/s12917-018-1684-9.
    [32]
    WILLIS GR, FERNANDEZ-GONZALEZ A, ANASTAS J, et al.Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation[J]. Am J Respir Crit Care Med, 2018, 197(1):104-116. DOI: 10.1164/rccm.201705-0925OC.
    [33]
    RIAZIFAR M, MOHAMMADI MR, PONE EJ, et al. Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders[J]. ACS Nano, 2019, 13(6):6670-6688. DOI: 10.1021/acsnano.9b01004.
    [34]
    KORDELAS L, REBMANN V, LUDWIG AK, et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease[J]. Leukemia, 2014, 28(4):970-973. DOI: 10.1038/leu.2014.41.
    [35]
    HABERTHEUER A, KORUTLA L, ROSTAMI S, et al. Donor tissue-specific exosome profiling enables noninvasive monitoring of acute rejection in mouse allogeneic heart transplantation[J]. J Thorac Cardiovasc Surg, 2018, 155(6):2479-2489. DOI: 10.1016/j.jtcvs.2017.12.125.
    [36]
    LIU Z, ZHANG Y, XIAO H, et al. Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase Ⅱ trial results[J]. Bone Marrow Transplant, 2017, 52(7):1080. DOI: 10.1038/bmt.2017.85.
    [37]
    GOTO T, MURATA M, TERAKURA S, et al. Phase Ⅰ study of cord blood transplantation with intrabone marrow injection of mesenchymal stem cells: a clinical study protocol[J]. Medicine (Baltimore), 2018, 97(17):e0449. DOI: 10.1097/MD.0000000000010449.
    [38]
    CETIN M, AKYOL G, GONEN ZB, et al. Additional infusions of mesenchymal stem cells improve response rate in multidrug-resistant GVHD patients[J]. Bone Marrow Transplant, 2017, 52(5):783-785. DOI: 10.1038/bmt.2017.1.
    [39]
    JURADO M, DE LA MATA C, RUIZ-GARCÍA A, et al. Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: a phase Ⅰ/Ⅱ study[J]. Cytotherapy, 2017, 19(8):927-936. DOI: 10.1016/j.jcyt.2017.05.002.
    [40]
    DOTOLI GM, DE SANTIS GC, ORELLANA MD, et al. Mesenchymal stromal cell infusion to treat steroid-refractory acute GVHD Ⅲ/Ⅳ after hematopoietic stem cell transplantation[J]. Bone Marrow Transplant, 2017, 52(6):859-862. DOI: 10.1038/bmt.2017.35.
    [41]
    WANG Z, YU H, CAO F, et al. Donor-derived marrow mesenchymal stromal cell co-transplantation following a haploidentical hematopoietic stem cell transplantation trail to treat severe aplastic anemia in children[J]. Ann Hematol, 2019, 98(2):473-479. DOI: 10.1007/s00277-018-3523-2.
    [42]
    SALMENNIEMI U, ITÄLÄ-REMES M, NYSTEDT J, et al. Good responses but high TRM in adult patients after MSC therapy for GVHD[J]. Bone Marrow Transplant, 2017, 52(4):606-608. DOI: 10.1038/bmt.2016.317.
    [43]
    VANIKAR AV, TRIVEDI HL, KUMAR A, et al. Co-infusion of donor adipose tissue-derived mesenchymal and hematopoietic stem cells helps safe minimization of immunosuppression in renal transplantation - single center experience[J]. Ren Fail, 2014, 36(9):1376-1384. DOI: 10.3109/0886022X.2014.950931.
    [44]
    PAN GH, CHEN Z, XU L, et al. Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study[J]. Oncotarget, 2016, 7(11):12089-12101. DOI: 10.18632/oncotarget.7725.
    [45]
    DETRY O, VANDERMEULEN M, DELBOUILLE MH, et al. Infusion of mesenchymal stromal cells after deceased liver transplantation: a phase Ⅰ-Ⅱ, open-label, clinical study[J]. J Hepatol, 2017, 67(1):47-55. DOI: 10.1016/j.jhep.2017.03.001.
    [46]
    PERICO N, CASIRAGHI F, TODESCHINI M, et al. Long-term clinical and immunological profile of kidney transplant patients given mesenchymal stromal cell immunotherapy[J]. Front Immunol, 2018, 9:1359. DOI: 10.3389/fimmu.2018.01359.
    [47]
    ZHANG YC, LIU W, FU BS, et al. Therapeutic potentials of umbilical cord-derived mesenchymal stromal cells for ischemic-type biliary lesions following liver transplantation[J]. Cytotherapy, 2017, 19(2):194-199. DOI: 10.1016/j.jcyt.2016.11.005.
    [48]
    REINDERS ME, DREYER GJ, BANK JR, et al. Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study[J]. J Transl Med, 2015, 13:344. DOI: 10.1186/s12967-015-0700-0.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (167) PDF downloads(13) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return